Ordering
Available Variants50 mg
CHA.63967-50mg
Price
€155.04
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.63967-50mg | €155.04 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C20H15ClN4 · 2HCl |
|---|---|
| CAS Number | 212141-51-0 |
| Molecular Weight | 419.73 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| MDL number | MFCD08458963 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Storage condition | desiccated |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Vatalanib dihydrochloride, with a CAS number of 212141-54-3, is a potent inhibitor of vascular endothelial growth factor receptors (VEGFRs) and platelet-derived growth factor receptors (PDGFRs). It has been investigated as a potential therapeutic agent for the treatment of various cancers, including colorectal, breast, and lung cancers. The compound works by blocking the tyrosine kinase activity of these receptors, which are involved in tumor angiogenesis and growth. Vatalanib dihydrochloride has shown promise in preclinical studies, demonstrating anti-tumor activity and inhibiting tumor growth in animal models. Its pharmacokinetic profile and safety have also been evaluated in clinical trials, providing valuable information for its potential use as a cancer therapy. Further research is needed to fully explore its therapeutic potential and optimize its use in clinical settings.
